We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TRANSPORT SECURES FUNDING FOR DELIVERY SYSTEM
TRANSPORT SECURES FUNDING FOR DELIVERY SYSTEM
November 24, 2004
Transport Pharmaceuticals has closed a $27 million Series D financing round to fund clinical development and commercialization of its therapy for herpes labialis, or cold sores.